Skip to content
Home/Companies/Healthcare/HistoGeneX

HistoGeneX

Healthcare·Belgium·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns HistoGeneX?

HistoGeneX was owned by Waterland Private Equity through Waterland Private Equity Fund VI (WPEF VI) (2015 vintage) from 2016 to 2019, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

Waterland Private Equity
Investor
Waterland Private Equity
Waterland Private Equity Fund VI (WPEF VI) · 2015 · Buyout

Key facts

HQBelgium
SectorHealthcare
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019

More from Waterland Private Equity Fund VI (WPEF VI)

Other portfolio companies in the same fund.

compassio
compassio
Active
HealthcareGermany· 2017
EMPWR (Vitamin Well Group)
Exited 2026
FoodTechBelgium· 2017
to
EMPWR Nutrition Group
Exited 2026
FoodTechBelgium· 2017
to
Enhesa
Enhesa
Exited 2020
Business ServicesBelgium· 2017
to
Nuts Groep
Active
EnergyNetherlands· 2017
Zentrum der Gesundheit
Zentrum der Gesundheit
Exited 2019
HealthTechGermany· 2017
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track HistoGeneX

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on HistoGeneX.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue